Salofalk 250
Salofalk 250 is a medicine authorised by Swissmedic under authorisation number 46673. The authorisation holder is Dr. Falk Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 December 1984 and the authorisation is valid without a time limit. ATC code A07EC02 places the medicine in the group Antidiarrheals, intestinal anti-inflammatory and anti-infective agents.
| Authorisation number | 46673 |
|---|---|
| Name | Salofalk 250 |
| Full name | Salofalk 250, Zäpfchen |
| Authorisation holder | Dr. Falk Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A07EC02 |
| First authorisation | 19 December 1984 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Salofalk 250, Zäpfchen | B | 19 December 1984 |
| 2 | Salofalk 500, Zäpfchen | B | 02 December 1986 |
| 3 | Salofalk 1g, Zäpfchen | B | 23 December 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 18 | 30 | Suppositorien | A07EC02 | 04.09.0. | B |
| 42 | 20 | Suppositorien | A07EC02 | 04.09.0. | B |
| 50 | 50 | Suppositorien | A07EC02 | 04.09.0. | B |
| 53 | 30 | Suppositorien | A07EC02 | 04.09.0. | B |
| 54 | 60 | Suppositorien | A07EC02 | 04.09.0. | B |
| 55 | 10 | Suppositorien | A07EC02 | 04.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Salofalk 250 authorised in Switzerland?
Yes. Salofalk 250 is authorised by Swissmedic under authorisation number 46673, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Salofalk 250 have?
Salofalk 250 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Salofalk 250?
The authorisation holder is Dr. Falk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.